Optimization of Darunavir Therapy and Dosage Recommendations

NCT03101644 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

127

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus I Infection

Interventions

DRUG: Darunavir

Sponsor

Université Catholique de Louvain

Collaborators

[object Object]